Previously, it was shown that CD8+ Tc1 cells able to produce IFNγ, similar to Tc2 (CD8+IL-4+) and Tc17 (CD8+IL-17A+) cells, were lowered in convalescent COVID-19 patients compared to control subjects [91]. This evidence concerns the gene CD8A and COVID-19.